Cheers to saving lives
Hoxworth Blood Center partners with local breweries
Hoxworth Blood Center, University of Cincinnati, is brewing up exciting blood donation opportunities this summer, partnering with local breweries throughout the Tri-State.
Now through the end of June, Hoxworth Blood Center will be visiting more than 15 local breweries with their mobile blood donation bus to provide unique opportunities to support the community through blood donation while also supporting local businesses.
“We know one thing that Cincinnati loves, and that is beer,” said Jackie Marschall, Hoxworth spokesperson. “And we also know that the greater Cincinnati community has a culture of giving back, so we’re excited to be able to combine both of those things for our Hoxworth donors this summer.”
Donors will receive a thank you gift from Hoxworth plus a gift from partners where applicable.
The blood donation process takes about one hour from arrival to post-donation snacks and will include a donor health questionnaire and mini physical.
For more information and to schedule at a brewery blood drive, visit: hoxworth.org/groups/brewtour, call 513-451-0910 or download the new Hoxworth Blood Donor app.
Featured photo at top of Hoxworth donor bus. Photo/Hoxworth Blood Center/University of Cincinnati.
About Hoxworth:
Hoxworth Blood Center, University of Cincinnati, was founded in 1938 and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky, and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home.
Related Stories
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.
Weight loss drugs help, but not on their own
January 5, 2026
Millions of Americans are on one type of weight loss drug or another, and a University of Cincinnati physician says there are things to know as we enter the new year. Malti Vij, MD, adjunct associate professor in the Department of Internal Medicine and provider at UC Health Primary Care in Mason, recently spoke to 91.7 WVXU News.